Search

everythinglearnresearchcommunity

for

Search:↓

Post-Finasteride Syndrome causes lasting sexual, mood, and metabolic issues, needing personalized treatment and better informed consent.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Two new compounds were found to effectively reduce hair growth in mice.

Baricitinib may effectively treat oral lichen planus.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

A cholesterol-free liposomal platform using protopanaxadiol effectively promotes hair growth and treats alopecia.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Reducing reactive oxygen species can help treat nerve damage from platinum cancer drugs.

Finasteride reduces sperm count and affects male reproductive function, while Epristeride does not.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Nonactivated low leukocyte PRP injections can significantly increase hair and follicle density in women with alopecia.

PRP therapy may help with ovarian issues and fertility, but more research is needed.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Long-Acting Platelet Rich Plasma therapy can effectively reduce hair shedding, thicken hair, and promote new growth in women with pattern hair loss.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Standardizing PRP preparation and application could improve its effectiveness for chronic pain relief.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Finasteride and levofloxacin effectively reduce chronic bacterial prostatitis severity.